{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:44:56Z","timestamp":1794296696708,"version":"4.9.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 54-year-old woman diagnosed with multiple endocrine neoplasia syndrome type 1 and primary hyperparathyroidism underwent total parathyroidectomy with autotransplantation of parathyroid tissue fragments in the right forearm in 1999. Since several years later, follow-up laboratory examinations showed the relapse of hypercalcemia; the patient started cinacalcet therapy. To exclude the presence of hyperfunctioning parathyroid glands in ortotopic or ectopic sites, a PET\/CT scan with <jats:sup>18<\/jats:sup>F-fluorocholine was performed. The PET\/CT scan excluded the presence of ortotopic and ectopic parathyroid glands but showed a hyperplastic parathyroid fragment in the right forearm, responsible for the patient\u2019s persistent hypercalcemia.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004916","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T23:03:52Z","timestamp":1697497432000},"page":"e580-e582","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["18F-Fluorocholine PET\/CT in the Detection of Hyperfunctioning Transplanted Parathyroid Tissue"],"prefix":"10.1097","volume":"48","author":[{"given":"Federico","family":"Garrou","sequence":"first","affiliation":[{"name":"Nuclear Medicine Unit, Department of Medical Sciences, AOU Citt\u00e0 della Salute e della Scienza, University of Turin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Rizzo","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Rosso","sequence":"additional","affiliation":[{"name":"Endocrinology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Bondi","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology, Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Racca","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.beem.2018.09.010","article-title":"Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-jaw tumour, familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism","volume":"32","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00259-021-05334-y","article-title":"The EANM practice guidelines for parathyroid imaging","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12020-022-03280-9","article-title":"18F-fluorocholine PET\/CT semi-quantitative analysis in patients affected by primary hyperparathyroidism: a comparison between laboratory and functional data","volume":"80","year":"2022","journal-title":"Endocrine"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00259-018-4123-z","article-title":"Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s00268-020-05880-w","article-title":"Letter to the editor: 18F-fluorocholine PET\/CT in MEN1 patients with primary hyperparathyroidism","volume":"45","year":"2021","journal-title":"World J Surg"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1007\/s00268-020-05695-9","article-title":"18F-fluorocholine PET\/CT in MEN1 patients with primary hyperparathyroidism","volume":"44","year":"2020","journal-title":"World J Surg"},{"key":"bib8-20250621","first-page":"130","article-title":"Multiple endocrine neoplasia type 1 or 4: detection of hyperfunctioning parathyroid glands with 18F-fluorocholine PET\/CT. Illustrative cases and pitfalls","volume":"66","year":"2022","journal-title":"Q J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:07:16Z","timestamp":1750532836000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004916","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,11]]}}}